Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Citius Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +4 vs. Q1 2026
- Shares held
- 1.36M
- +362.6K (+36.4%) vs. Q1 2026
- Total value
- $822.4K
- −$74.5K (−8.3%) vs. Q1 2026
- New holders
- 12
- 8 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 42 | $822.4K |
| Q1 2026 | 38 | $896.9K |
| Q4 2025 | 39 | $1.34M |
| Q3 2025 | 34 | $773.2K |
| Q2 2025 | 31 | $1.48M |
| Q1 2025 | 28 | $947.2K |
| Q4 2024 | 30 | $2.43M |
| Q3 2024 | 58 | $11.8M |
| Q2 2024 | 72 | $17.9M |
| Q1 2024 | 73 | $24.2M |
| Q4 2023 | 74 | $20.3M |
| Q3 2023 | 74 | $17.1M |
| Q2 2023 | 75 | $30.4M |
| Q1 2023 | 56 | $16.9M |
| Q4 2022 | 54 | $11.2M |
| Q3 2022 | 57 | $16.6M |
| Q2 2022 | 60 | $14.0M |
| Q1 2022 | 76 | $43.2M |
| Q4 2021 | 77 | $37.6M |
| Q3 2021 | 71 | $51.1M |
| Q2 2021 | 74 | $87.6M |
| Q1 2021 | 39 | $19.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bogart Wealth, LLC | 4 | $2 | 0.00% | 00.0% | Unchanged |
| Fairscale Capital, LLC | 42 | $25 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 44 | $27 | 0.00% | −1,320−96.8% | Reduced |
| Federation des caisses Desjardins du Quebec | 80 | $48 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 84 | $51 | 0.00% | +84 | New |
| BNP Paribas Arbitrage, SA | 107 | $65 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 120 | $69 | 0.00% | 00.0% | Unchanged |
| Smallwood Wealth Investment Management, LLC | 120 | $72 | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 160 | $97 | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 372 | $225 | 0.00% | 00.0% | Unchanged |
| Luminist Capital LLC | 435 | $263 | 0.00% | +435 | New |
| Wells Fargo & Company | 1,000 | $605 | 0.00% | +1,000 | New |
| Barclays PLC | 1,096 | $663 | 0.00% | +1,096 | New |
| Simplex Trading, LLC | 1,256 | $759 | 0.00% | +1,256 | New |
| Group One Trading, L.P. | 1,551 | $938 | 0.00% | +1,551 | New |
| Advisor Group Holdings, Inc. | 2,575 | $1.54K | 0.00% | −160−5.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,724 | $1.65K | 0.00% | −61−2.2% | Reduced |
| IFP Advisors, Inc | 4,183 | $2.53K | 0.00% | −2,900−40.9% | Reduced |
| Quent Capital, LLC | 4,232 | $2.56K | 0.00% | −33−0.8% | Reduced |
| Chelsea Counsel Co | 4,626 | $2.80K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 9,519 | $5.75K | 0.00% | +3,000+46.0% | Added |
| Two Sigma Securities, LLC | 10,006 | $6.05K | 0.00% | +10,006 | New |
| R Squared Ltd | 11,033 | $6.67K | 0.00% | +11,033 | New |
| Susquehanna International Group, LLP | 11,795 | $7.13K | 0.00% | −25,043−68.0% | Reduced |
| Sanctuary Advisors, LLC | 11,810 | $7.14K | 0.00% | +11,810 | New |
| Two Sigma Investments, LP | 17,494 | $10.6K | 0.00% | +4,356+33.2% | Added |
| Arkadios Wealth Advisors | 20,000 | $12.1K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 20,836 | $13.0K | 0.00% | +20,836 | New |
| State Street Corp | 23,271 | $14.1K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 25,445 | $15.4K | 0.00% | +400+1.6% | Added |
| UBS Group AG | 26,335 | $15.9K | 0.00% | −28,690−52.1% | Reduced |
| BostonPremier Wealth LLC | 28,000 | $16.9K | 0.01% | +28,000 | New |
| Asset Advisory Group, Inc. | 59,011 | $35.7K | 0.02% | 00.0% | Unchanged |
| XTX Topco Ltd | 59,199 | $35.8K | 0.00% | +37,904+178.0% | Added |
| Northern Trust Corp | 62,742 | $37.9K | 0.00% | +18,768+42.7% | Added |
| BlackRock, Inc. | 69,850 | $42.2K | 0.00% | −10.0% | Reduced |
| Vanguard Fiduciary Trust Co | 77,755 | $47.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 122,837 | $74.3K | 0.00% | +100,314+445.4% | Added |
| Citadel Advisors LLC | 124,910 | $75.5K | 0.00% | +124,910 | New |
| Miller Financial Services LLC | 130,000 | $78.6K | 0.06% | +116,000+828.6% | Added |
| Vanguard Capital Management LLC | 197,364 | $119.4K | 0.00% | +29,626+17.7% | Added |
| Geode Capital Management, LLC | 215,537 | $130.3K | 0.00% | −30,621−12.4% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −60,332−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,228−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −1,788−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Murphy & Mullick Capital Management Corp | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |